Dishman Pharma Q2 net profit surges near two-fold to Rs 55 cr

The company had posted a net profit after taxes, minority interest and share of profit/(loss) of the associates of Rs 27.73 crore for the corresponding period year ago, Dishman Pharmaceuticals said in a BSE filing.

October 27, 2016 / 15:09 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Dishman Pharmaceuticals and Chemicals today reported a near two-fold jump in consolidated net profit to Rs 54.68 crore for the second quarter ended September 30, mainly on account of robust sales in contract research and manufacturing services segment.

The company had posted a net profit after taxes, minority interest and share of profit/(loss) of the associates of Rs 27.73 crore for the corresponding period year ago, Dishman Pharmaceuticals said in a BSE filing.

Consolidated total income from operations also rose to Rs 436.55 crore for the quarter under review as against Rs 380.39 crore in the same period last fiscal.

The stock was trading 5.23 percent up at Rs 239.50 on BSE.

first published: Oct 27, 2016 02:58 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347